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peutic management.  © 2014 S. Karger AG, Basel 
 Introduction 
 Squamous cell carcinoma (SCC), along with basal cell 
carcinoma, is one of the most common non-melanoma 
skin cancers. Actinic keratosis is considered as a precur-
sor lesion of SCC. The treatment of choice is usually exci-
sion. As the diagnosis is often established at an early stage, 
rates of local recurrences or metastases are low. The risk 
of metastases in non-melanoma skin cancer (2–3% in 
SCC, <0.01% in basal cell carcinoma) is much smaller 
compared to malignant melanoma  [1, 2] . However, it 
does occur. Indicators of poor prognosis for local recur-
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 Abstract 
 Background: Perineural invasion (PNI) in cutaneous squa-
mous cell carcinoma (SCC) is considered to be a negative 
prognostic factor. A lot of uncertainty remains regarding the 
classification, diagnosis, treatment and prognosis of SCC 
with PNI.  Objective: To describe typical courses of SCC with 
PNI and associated findings in order to suggest an optimized 
diagnostic and therapeutic approach.  Methods: We present 
eight cases of SCC with PNI, considering patient and tumor 
characteristics, histology, treatment and clinical course re-
garding local recurrence and metastasization.  Results: SCC 
patients with PNI have a higher rate of local recurrences 
and greater risk for metastasization than SCC patients with-
out PNI. Age ranged from 68 to 77 years, 6 patients were 
male and 2 female, with all tumors localized on the head. 
Three patients had chronic lymphocytic leukemia.  Conclu-
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rences and metastatic disease in SCC are tumors >2 cm in 
diameter, tumor thickness  ≥ 2 mm, poorly differentiated 
tumors, invasion into or below the reticular dermis, areas 
of previous irradiation, immunosuppression and – more 
recently acknowledged – perineural invasion (PNI)  [3–
5] . PNI was first described a century ago as the spread of 
tumor cells along the nerves just beneath the perineurium 
 [6] . During the last two decades an increasing number of 
reports of PNI in SCC have been published. This tumor 
spread along the loose connective tissue of the perineu-
rium is unpredictable and difficult to treat. Invasion of 
tumor cells into a cranial nerve may lead to invasion into 
the brain stem. Unfortunately, there is a lot of uncertain-
ty regarding the classification, diagnosis, treatment and 
prognosis of SCC with PNI  [7] . We describe eight cases 
of SCC with PNI and describe our reasoning on establish-
ing the diagnosis and treatment of this entity, reviewing 
the current literature.
 Case Presentation ( table 1 ) 
 Patient 1 
 A 75-year-old Caucasian man consulted our clinic for a recur-
rent SCC on the forehead. Physical examination revealed multiple 
erythematous plaques with yellow crusts of 3 × 3 cm on the left side 
of the forehead. As the patient also suffered from chronic lympho-
cytic leukemia (CLL), the enlarged palpable cervical lymph nodes 
were sonographically assessed as lymph nodes consistent with the 
known CLL. Histopathology of the tissue from the left side of the 
forehead revealed SCC with scar tissue and clear excision margins. 
One year later the patient presented with a recurrent tumor of 
1.5 × 1.5 cm again on the left side of the forehead ( fig. 1 a). On 
clinical evaluation the patient had an impairment of the frontal 
branch of the facial nerve (clinical PNI, cPNI). Histology showed 
an incompletely removed SCC with PNI; a metastasis could not be 
excluded. One month later we saw the patient for re-excision. In-
traoperatively the tumor could be followed down to the left or-
bital rim ( fig. 1 b). Excision showed again an incompletely excised 
SCC with a locoregional metastasis with PNI. The thickness of the 
nerves involved was 0.08–0.15 mm at first and 0.25–0.35 mm at 
second excision. Staging showed no evidence of intracranial me-
tastases (PET scan and MRI). Due to the aggressive behavior of the 
tumor we consulted the oral and maxillofacial surgeons. They per-
formed two re-excisions along the supraorbital nerve. The patient 
developed metastases on the left upper eyelid with infiltration of 
the left orbit and in the area of the sinus cavernosus. This resulted 
clinically in upper eyelid ptosis and the patient complaining of 
double vision. He received radiotherapy (RT) for the metastasis of 
the left orbit (48.0 Gy in 6 fractions). The patient died 16 months 
after diagnosis of SCC with cPNI of unknown cause.
 Patient 2 
 A 70-year-old Caucasian man presented with a recurrent SCC 
on the right temple with previous incomplete excision. Physical 
examination revealed a 5 × 5 cm ulcerated and hemorrhagic tumor 
with no clinical signs of nerve involvement. No palpable head or 
neck lymphadenopathy was identified. Our first excision was again 
incomplete, re-excision was histologically complete. However, 2 
months later the patient presented with a recurrence. Again we 
excised the tumor and histology showed free margins. Three 
months later the patient presented again with a recurrence and an 
additional periauricular tumor on the right side. Histology of both 
excisions revealed completely removed SCCs. A CT scan showed 
a local recurrence on a large area of the scalp. Ultrasound of the 
cervical lymph nodes and of the abdomen showed no evidence of 
metastases. Given the aggressive behavior of this tumor and the 
presence of PNI, the patient was referred for adjuvant RT, which 
a
b
 Fig. 1.  a A 75-year-old Caucasian male with a recurrent SCC on 
the left forehead. Excision showed an incompletely removed SCC 
with PNI, possibly a metastasis.  b Intraoperatively the tumor could 
be followed down to the left orbital rim. The tip of the forceps 
points to the SCC surrounding the supraorbital nerve. Excision 
showed an incompletely excised SCC with locoregional metastasis 
with PNI. 
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he completed. Four months later he presented with a 2 cm SCC on 
the scalp, which we excised with histologically free margins. Be-
cause of the multiple recurrences, status after broad excisions with 
split skin grafts and status post adjuvant RT, the patient was re-
ferred to the oral and maxillofacial surgeons for further care and 
was then lost to follow-up.
 Patient 3 
 A 68-year-old Caucasian woman presented to our clinic with 
an incompletely removed SCC on the forehead that had been pre-
viously treated elsewhere using serial excisions  [4] with signs of 
clinical nerve involvement. The patient had lymphadenopathy of 
unknown origin; ultrasound did not show any evidence of metas-
tases. We completely removed the ulcerated SCC that revealed PNI 
with a thickness of nerves involved of 0.07–0.13 mm. Two months 
later a recurrent tumor was again excised with histologically free 
margins and again showed a SCC without PNI. 20 months later the 
patient had to undergo a large surgery with large excision, bone 
removal and a large flap to cover the defect due to a relapse of the 
tumor. Multiple postoperative complications occurred with a 
stroke and the patient is currently being treated at an intensive care 
unit.
 Patient 4 
 A 68-year-old Caucasian man presented to our clinic with an 
incompletely removed SCC with PNI and lymphangiosis carcino-
matosa along the scar on the left temple. We performed a re-exci-
sion with a safety margin of 1.0 cm. PET and CT scan of the head 
and ultrasound of the lymph nodes showed no evidence of metas-
tases. Given the aggressive behavior of the tumor the patient re-
ceived adjuvant RT (60.0 Gy). He did not develop a relapse during 
the 3-year follow-up period.
 Patient 5 
 A 77-year-old Caucasian woman presented with a recurrent 
SCC on the forehead. Physical examination showed three nodules 
at the site of the first excision that had previously been closed by 
skin graft ( fig. 2 a). They had been rapidly and progressively grow-
ing for 1 month. We excised these lesions and 3D histology showed 
SCCs with PNI. One month later the patient presented with two 
new tumors of 1 × 2 cm at the margin of the latest scar ( fig. 2 b). 
Histology again showed a SCC with PNI. Ultrasound revealed 
echo-poor cervical, preauricular and nuchal structures compatible 
with cutaneous and lymph node metastases. MRI of the head and 
neck showed multiple pathological lymph nodes along the nerves, 
while staging of the thorax and abdomen using ultrasound, X-ray 
and CT revealed no evidence of metastases. Given the aggressive 
behavior of the tumor the ear-nose-throat surgeon was consulted. 
He performed extensive excision including neck dissection and 
referred the patient for adjuvant RT. During radiation new tumors 
developed at the border of the radiation field which in turn had to 
be extended. The tumors regressed. However, the patient devel-
oped new and extended metastases 3 months later and was again 
treated by radiation. This time the tumors did not regress during 
therapy. The patient presented to our clinic with an ulcerated tu-
mor of 10 cm in diameter on the left temple. Histopathology again 
showed local recurrence of the aforementioned SCC. In addition 
multiple nodules of up to 1.5 cm, consistent with metastases, had 
developed. The patient refused further staging and died a few 
months later, 2 years after the first diagnosis of SCC with PNI.
 Patient 6 
 A 69-year-old man presented to our clinic with a 1.5 × 1.5 cm 
erythematosquamous plaque on the right parietal region, with 
clinical signs of nerve involvement. No lymph nodes were palpable 
on the head or the neck. Histology identified a SCC with PNI and 
margins free of tumor. Fifteen months later he presented with new 
nodules in the surgical area that had developed within 4 weeks. 
Physical examination revealed a tumor of 2 cm on the right side of 
 Fig. 2.  a A 77-year-old Caucasian with recurrence of a SCC (ex-
cised elsewhere) on/at the border of the defect. Excision was com-
plete (3D histology).  b One month later the patient presented with 
two new tumors of 1.0 × 2.0 cm at the edge of the scar. Excision 
showed a completely removed SCC with PNI (3D histology). 
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the forehead, and an infiltrative 2 × 2 cm plaque with hyperkera-
tosis on the skull. Histology described an incompletely removed 
SCC on the right side of the forehead. Complete resection of the 
tumor was not possible, although the periosteum of the right fron-
tal region had been included. CT and PET scans showed signs of 
scar tissue or residual tumor cells, but no evidence of metastases. 
Given the aggressive behavior of the tumor the patient was referred 
to the oral and maxillofacial surgeons and to the neurosurgeons, 
who performed radical resection down to the level of the tabula 
externa, which again was incomplete. As no further excision was 
possible, RT was added with a cumulative dose of 66.0 Gy. During 
the follow-up period of 11 months the patient did not show any 
relapse.
 Patient 7 
 A 77-year-old man with a 3 × 3 cm exophytic and ulcerated 
erythematous tumor was referred to our clinic. Histology revealed 
a poorly differentiated SCC 6.5 mm in thickness with PNI. An-
other four excisions were necessary to achieve tumor-free bor-
ders, creating a defect of approximately 20 × 30 cm; a mesh graft 
was used to cover the defect. Untreated CLL had been known for 
10 years. Ultrasound of the neck showed no pathologically en-
larged lymph nodes. During the follow-up period of 8 months 
there was no evidence of relapse or metastases.
 Patient 8 
 The patient was a 69-year-old man. Six months prior to referral 
a moderately differentiated SCC of 1.6 cm in thickness on the left 
cheek had been incompletely excised at an outside facility. Five 
months post intervention an ulceration had developed in the mid-
dle of the scar. Biopsy revealed diffuse and infiltrative SCC with 
PNI. Upon examination the patient showed weakness of the 
branches of the facial nerve on the left side, either as a result of sur-
gery or of PNI. We excised the area (5.5 × 4.5 cm) reaching into 
Bichat’s fat pad and the mimic muscles. Ultrasound of the neck 
showed a suspicious lymph node on the left side. Since the tumor 
could not be excised completely in all directions, the patient was 
referred to the oral and maxillofacial surgeons for extensive exci-
sion and neck dissection which was incomplete, followed by adju-
vant RT up to 65.5 Gy. Follow-up of 6 weeks since the end of RT 
has not revealed any signs of relapse. The patient is known to have 
CLL and had previously been treated three times by chemother apy.
 Discussion 
 Our cases follow the typical characteristics for SCC 
with PNI: older patients with recurrent and/or multiple 
incompletely excised SCCs ( tables 1 ,  2 )  [2, 8–17] . Most of 
 Table 1.  Patient characteristics
Pa tient 
No.
Age at 
excision
Sex Histological 
subtype, 
differentiation
Location Primary/
recurrent, 
thickness of 
infiltrated nerve
Clinical 
tumor size 
(cm2)
Exci-
sions 
(n)
Staging 
for 
metastasis
RT Under-
lying 
disease
1 75 m poorly
cPNI
left 
forehead
recurrent
0.08 – 0.15 mm
9 6 + + CLL
2 70 m poorly
aPNI
right 
temple
recurrent
0.12 mm
25 5 – +
3 68 f moderately
cPNI
forehead primary*
0.07 – 0.13 mm
* 5 + –
4 68 m poorly
aPNI
left 
temple
primary*
0.1 mm
* 1 – +
5 77 f poorly
aPNI
forehead recurrent
0.25 mm
7 3 + +
6 69 m moderately
cPNI
parietal 
right
primary
0.3 mm
4 4 – +
7 77 m poorly
aPNI
parietal 
right
recurrent
0.3 mm/
multiple nerves
9 5 + – CLL
8 69 m poorly
cPNI
left 
cheek
primary*
0.1 mm
* 3 + – CLL
 Thickness of nerve measurements were performed on the tissue that was gathered on the first excision at our department. * Removed 
elsewhere.
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 Table 2. Previous publications of SCC with PNI
Ref. 
(first 
author)
Spe-
cialty
Tu-
mors 
with 
PNI
Male 
(%)
Age His-
tology 
(%)
cPNI 
(%)
LN/
metas-
tases 
(%)
Recur-
rence 
(%)
Location Size 
>2 cm 
(%)
Prior 
therapy
Treatment 
type (%)
FU CSS Recur-
rence 
(%)
Geist 
[2]
MMS 8 63 71 p 4, 
m 3, 
w 1
0 13 ck 2, fh 3, 
ll 2, ar 1
50 MMS 3 – 32 100 0
Reule 
[3]
MMS 2 100 70 m 2 50 0 scalp 1 100 cu 1, se MMS 15 – 28 100 0
Leibovitch 
[8]
MMS 70 54 65 p 29, 
w 7, 
m 54, 
a 7
0 0 49 ar 26, ck 21, 
fh 19
56 c 14, cu 1, 
se 31, RT 1
MMS + xRT 53, 
MMS 47
60 100 8
Lawrence 
[9]
MMS 44 86 75 bg1 7, 
bg2 – 3 
93 
0/3 57 fh 20, ck 14, 
tp 11, ll 11
70 c 12, cu 56, 
se 40, RT 12, 
MMS 12
MMS 36 – 72 89 7
Goepfert 
[10]
HNS 
+ RT
72 88 64 t 80, 
as 13, 
sc 7
40 35/15 83 V1 10, V2 47, 
V3 13, VII 30
24 46
Cottel 
[11]
MMS 17 82 68 29 0/6 65 ck 35, fh 29, 
l 12
82 se 41, cu 29, 
xRT 18, 
MMS 6
MMS 41, 
MMS + xRT 35, 
MMS + xRT + se 
12, xRT + se 6, se 6
16 100 0
Catalano 
[12]
sur-
gery
6 67 63 100 17/0 5/6 pa 1, el 1, tp 2, 
ck 1, ll 1
se 4, 
se + RT 2
parotidectomy 
+ xRT
10 – 24 100 1
Ampil 
[13]
sur-
gery
9 78 63 33 0 n 1, pa 1, 
ck 1, fh 1, 
io 2, tp 1, ll 2
78 wse 2, 
se + xRT 3, 
se 4
18 – 201 100 33
Lesnik 
[14]
sur-
gery
1 100 59 100 0 0 ck 1 mastoidectomy 
+ RT
6 100 0
Panizza 
[15]
HNS 21 71 60 100 0 24 n 6, tp 2, ck 2, 
pa 1, a 1, ns 6
se 12, 
se + RT 5, 
supraorbital 
nerve 
resection 1
wse + RT 20, 
parotidectomy 1
100 64 35
Lin 
[16]
133 78 72 0 6 18 S1 22, S2 57, 
S3 21
se 96, RT 4 42 22
Campoli 
[17]
MMS 35 72 78 p 37, 
m 63
0 5/7 – S1 and 
S2 91%, 
S3 9%
66 – MMS – – –
Carter 
[28]
144 71 71 p 17, 
m 55, 
w 28
– 9/6 – – 20 – MMS 15, 
se 79, RT 1, ns 5
132 93 16
a = Acantholytic; ar = auricular; as = adenosquamous; bg = Broders’ classification grade; c = cryosurgery; ck = cheek; CSS = cause-specific survival; cu = 
curettage; fh = forehead; FU = follow-up period (months); HNS = head and neck surgery; io = infraorbital; l = lip; ll = lower lip; LN = lymph nodes; m = 
moderately differentiated; n = nodulocystic; ns = not specified; p = poorly differentiated; pa = preauricular; S1 = site 1: forehead, eyebrow, upper eyelid, in-
ner canthus, lower eyelid, nose, nasolabial sulcus; S2 = site 2: scalp, preauricular, parotid, mandible, lower lip, chin, temple, upper lip, cheek; S3 = site 3: other 
(outside head and neck); sc = spindle cell; se = surgical excision; t = typical; tp = temple; V1 = nervus ophthalmicus; V2 = nervus maxillaris; V3 = nervus 
mandibularis; VII = nervus facialis; w = well differentiated; wse = wide surgical excision; xRT = adjuvant RT.
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our patients were 60 years or older, and an average of four 
excisions were necessary for complete removal. This is 
consistent with the current literature. However, the lit-
erature on SCC with PNI is scarce. Recently an incidence 
of 4.6% was found in 753 cutaneous SCC cases  [17] . The 
histological subtype described in our series was mostly of 
poor or moderate differentiation, also in concurrence 
with previous publications ( table 2 ). The tumors in our 
series presented only in the head and neck region, just as 
described in the literature. All patients presented with a 
tumor size of >2 cm. We mainly referred them (next to 
adjuvant RT) to the oral maxillofacial surgeon for wide 
excision and lymph node dissection – more frequently 
than described in the literature.
 There are two groups of patients described in the lit-
erature. One group consists of patients with cPNI, who 
suffer from clinical symptoms of damaged nerves, and the 
other group comprises patients without neurological 
symptoms (asymptomatic PNI, aPNI). aPNI is an inci-
dental finding on histological examination. Most cases 
described in the literature are cPNI ( table 2 ). Regarding 
the prognosis it is important to differentiate between 
these two groups. Patients with cPNI have a higher rate 
of recurrence and metastases compared to patients with 
aPNI  [3, 7] . Unfortunately, these two populations are of-
ten combined and not clearly distinguished in most pub-
lications. Also the definition of cPNI is not used uniform-
ly. Some authors define cPNI as a patient with clinical 
neurological symptoms, while others rely on positive 
findings on imaging. In our patients four out of eight pre-
sented with cPNI on clinical investigation. Furthermore, 
there are many reports of skin carcinoma in general 
(without differentiation of type) and PNI. They describe 
that most tumors are SCCs and few are basal cell carcino-
mas, but a clear distinction is rarely made. As seen in 
 table 2 , most patients are male, with a mean age of 60–
70 years. The predominant histological subtype (if de-
scribed) is moderate to poor differentiation. One study 
describes lymph node metastases to be present in 35% of 
cases  [10] . In other studies this number is lower; however, 
fewer patients were included in these studies. A large 
number of SCCs with PNI are recurrent tumors (13–83%, 
 table 2 ). First-line therapy was standard surgical excision 
in most cases, and to a lesser extent cryotherapy, electro-
cautery and curettage or shave excision. In most cases tu-
mor size was >2 cm, but smaller tumors are also men-
tioned ( table 2 ). The risk of metastases increases with tu-
mor thickness. We assume that the risk of cPNI increases 
with tumor thickness as well as with tumor diameter 
(>2 cm). This requires further investigation.
 There are three diagnostic instruments to identify SCC 
with PNI: (1) patient history with neurological examina-
tion to diagnose neuropathy/nerve involvement, (2) histo-
logical evaluation of specimens and (3) radiographic im-
aging. The physician should ask about facial pain, dyses-
thesia, tingling, burning and shooting pain or formication. 
Increasing numbness or pain is an important signal for 
nerve involvement. Physical examination should include 
a neurological status focused on motor impairments (fa-
cial weakness, ptosis, diplopia, blurred vision, ophthalmo-
plegia, fasciculations). Given the 24% of lymph node me-
tastases in PNI in the study of Goepfert et al.  [10] , we think 
that a thorough lymph node examination using ultra-
sound should be mandatory. Tumor cells may only show 
subtle signs of atypia. Even perineural inflammation can 
be a sign of PNI and further research concerning histo-
pathological features of PNI is necessary. Green et al.  [18] 
stated that Mohs frozen tissue sections would be better to 
identify SCC with PNI than paraffin-embedded tissue sec-
tions. Patients with cPNI have reduced alpha B-crystallin 
staining; whether this is also true for aPNI is not known 
yet  [19] . p75 NGFR staining (a nerve growth factor recep-
tor) could also offer a clue in PNI  [20] . However, perivas-
cular cells, basal cells of the epidermis, basal layers of hair 
follicles and sweat glands are also p75 NGFR-positive, so 
this staining is not highly specific. S100 staining (marking 
the axon) can also be helpful. The use of both stainings is 
advisable. Laminin 5 and plasminogen activator inhibitor 
1 are also described as staining possibilities. A limitation 
may be skip lesions. Skip lesions are (1) processing arte-
facts, (2) inflammation with tumor regression or (3) a true 
skipping of regions of nerves as single tumor cells travel 
along the length of a nerve, making false-negative histo-
logical examination possible  [3] . Recent investigations 
confirm former data that skip lesions in fact do not really 
exist  [21] . Furthermore, Ross et al.  [22] described that the 
chance of metastasis increases with the diameter of the in-
volved nerve (>0.09 mm). Lin et al.  [16] noted that nerves 
affected up to 1 mm did not affect survival, whereas infil-
tration of thicker nerves did. In our patients no clear as-
sociation between thickness of infiltrated nerves and prog-
nosis could be seen, probably due to the small number of 
patients. Especially in patients 1 and 3 with worse outcome 
we could not see any rule for course of their disease. In 
patient 1 the thickness of nerves involved was 0.08–0.15 
mm at first excision and developed to 0.25–0.35 mm at 
second excision, associated with the growth of the tumor 
along the lateral branch of the supraorbital nerve, which 
might be an explanation for the progression of the disease. 
On the other hand in patient 3 the thickness of the nerves 
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involved at first surgery was 0.07–0.13 mm and there was 
no evidence of nerve involvement at second excision. If 
large nerves ( ≥ 1 mm) are invaded, additional risk factors 
like a diameter of  ≥ 2 cm, infiltration of subcutaneous fat 
and multiple nerve involvement may be found, as well as 
an increased risk of nodal metastases  [23] .
 Treatment of SCC with PNI is a challenge. There are 
no randomized controlled trials comparing standard sur-
gical treatment with Mohs micrographic surgery (MMS) 
or randomized controlled trials comparing surgery with 
and without adjuvant RT. The type of treatment in our 
series was MMS with adjuvant RT in 5 cases and MMS 
alone in 3 cases. The study of Solares et al.  [23] is note-
worthy because they treated with wide excision combined 
with adjuvant RT. When MMS was applied, the mean 
number of surgical steps necessary for complete tumor 
removal was between two and five ( table 2 )  [23] . How-
ever, in most publications the number of interventions 
was not mentioned. In publications with larger numbers 
of patients, the rate of recurrence was higher than in 
smaller case series ( table  2 ). Thorough radical excision 
seems to be mandatory. MMS is thought to be superior to 
standard surgical excision because there is a greater sen-
sitivity to detect PNI and a lower rate of recurrence  [24] . 
Local control rates for SCC with PNI achieved by MMS 
versus standard excision, with or without postoperative 
RT, ranged from 92 to 100% for MMS and from 38 to 87% 
for standard excision  [3] . Cause-specific survival rates 
varied from 100 to 64% ( table 2 ). This may play a role for 
aPNI to better achieve tumor-free boarders. On the other 
hand, for patients with cPNI, MRI imaging should be per-
formed prior to surgery since with modern 3T MR neu-
rography techniques the extent of nerve involvement may 
be seen and surgery planned thereafter. RT in a curative 
or adjuvant manner is another option. Adjuvant RT can 
be used for tumor destruction in places difficult to reach 
(skull base, cranial cavity) or to destroy remaining tumor 
cells after excision  [25] . Its efficacy has not been evalu-
ated so far in SCC with PNI. There is no known random-
ized controlled trial comparing surgery alone versus sur-
gery combined with adjuvant RT. Since SCC with PNI 
behaves aggressively, frequent recurrence, metastasis and 
a poorer prognosis are evident. Due to concerns regard-
ing the reliability of surgical margins, adjuvant RT is ad-
vised  [25] . Criteria for adjuvant RT are lymph node me-
tastases, positive resection margins, poor differentiation, 
perivascular invasion and tumor size >2 cm. Most pa-
tients treated with adjuvant RT had SCC with cPNI. The 
efficacy of surgical excision combined with adjuvant RT 
was seen to be 38–87%  [3] . Whether adjuvant RT could 
also be beneficial in patients with SCC with aPNI is not 
known. Some authors state that patients with aPNI bear 
a risk of subclinical disease in the regional lymph nodes 
and therefore favor adjuvant RT  [26, 27] . The choice 
should be made individually for each patient.
 Looking at the data of our patients and at the published 
literature we think that radiographic imaging and adju-
vant RT in cutaneous SCC with PNI may be considered, 
but only when one or more additional risk factors (male, 
>6th decade of life, tumor >2 cm in diameter, tumor thick-
ness >5 mm, moderate to poor tumor cell differentiation, 
clinical symptoms of neuropathy, diameter of nerves in-
volved  ≥ 0.1 mm) are present. Up to now there are no clin-
ical studies showing an improved outcome for patients 
undergoing radiographic imaging prior to surgery.
 Conclusions 
 Recurrent and/or large and/or poorly differentiated 
cutaneous SCCs often bear a higher risk of PNI. Patients 
with neurological symptoms and/or positive MRI find-
ings have a poorer prognosis.
 Radiographic studies as expected cannot detect aPNI, 
and although in the past they have missed cPNI, with 
modern imaging sequences this is becoming far less fre-
quent.
 In histology, staining with laminin 5, p75 NGFR and 
S100, plasminogen activator-1 and neural cell adhesion 
molecule can help in identifying PNI.
 In aPNI, MMS is recommended as a method superior 
to standard excision. Radiographic imaging and adjuvant 
RT may be considered, but only if additional risk factors 
(male, >6th decade of life, tumor >2 cm in diameter, tu-
mor thickness >5 mm, moderate to poor tumor cell dif-
ferentiation, clinical symptoms of neuropathy, diameter 
of nerves involved  ≥ 0.1 mm) are present, although a 
higher efficacy has not been proven in controlled trials.
 In cPNI, MRI is an option to possibly estimate the ex-
tent of infiltrated nerves prior to wide surgical excision, 
yet there are no evidence-based data proving a benefit for 
the patients. Surgery should be followed by RT.
 Furthermore, we advise frequent and long-term follow-
up in these patients to identify recurrences at an early stage.
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